GlassScriptPhysician profile
Jose A Goris
NPI 1790714962
$22,838.02
in general payments reported to CMS, 2019-2025
63 companies · $3,639 in 2025
The $3,639 reported for 2025 was more than what 98% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,309 · 2020: $2,363 · 2021: $5,183 · 2022: $3,283 · 2023: $3,749 · 2024: $2,311 · 2025: $3,639.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,699.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,361.21 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,821.73 | 2019-2025 | Xifaxan, Relistor, Trulance |
| Astrazeneca Pharmaceuticals LP | $1,593.01 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $1,469.09 | 2019-2025 | Trelegy Ellipta, Nucala, Shingrix |
| Novo Nordisk INC | $1,441.21 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Biohaven Pharmaceuticals, INC. | $1,355.35 | 2021 | |
| Novartis Pharmaceuticals Corporation | $891.99 | 2019-2025 | |
| Allergan, INC. | $847.99 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $804.36 | 2019-2025 | Jardiance |
| Amgen INC. | $558.46 | 2019-2025 | Repatha, Otezla, Otezla |
| Pfizer INC. | $554.76 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $550.99 | 2020-2024 | Eliquis, Camzyos |
| Astellas Pharma US INC | $547.48 | 2019-2024 | Veozah, Myrbetriq |
| Intra-Sana Laboratories | $519.25 | 2023-2025 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $495.65 | 2024-2025 | Caplyta |
Show all 63 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $468.47 | 2024-2025 | Recorlev, Gvoke Hypopen |
| Daiichi Sankyo INC. | $459.72 | 2021-2023 | Injectafer |
| Merck Sharp & Dohme LLC | $390.69 | 2019-2023 | Verquvo, Belsomra, Steglatro |
| Bayer Healthcare Pharmaceuticals INC. | $340.06 | 2021-2025 | |
| Exact Sciences Corporation | $325.75 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Gilead Sciences, INC. | $306.26 | 2023-2025 | Biktarvy |
| Takeda Pharmaceuticals U.S.A., INC. | $304.07 | 2019-2025 | Trintellix |
| Amarin Pharma, INC. | $296.76 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $291.50 | 2019-2022 | |
| Horizon Therapeutics Plc | $278.62 | 2019-2022 | |
| Esperion Therapeutics, INC. | $252.51 | 2020-2023 | Nexletol |
| Sanofi-Aventis U.S. LLC | $250.83 | 2020-2023 | |
| Teva Pharmaceuticals USA, INC. | $244.25 | 2021-2024 | Austedo Xr |
| Otsuka America Pharmaceutical, INC. | $226.22 | 2023-2025 | Rexulti, Nuedexta |
| Insulet Corporation | $218.13 | 2019-2025 | Omnipod |
| Alkermes, INC. | $195.92 | 2022-2025 | Vivitrol, Aristada, Vivitrol |
| Lundbeck LLC | $159.89 | 2022-2025 | Rexulti |
| Phathom Pharmaceuticals, INC. | $156.00 | 2025 | Voquezna |
| Ironwood Pharmaceuticals, INC | $136.27 | 2020-2023 | Linzess |
| Mannkind Corporation | $130.01 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $122.91 | 2024-2025 | Gemtesa |
| Ardelyx, INC. | $115.20 | 2023-2025 | Ibsrela |
| Corcept Therapeutics | $114.76 | 2023 | Korlym |
| Lilly USA, LLC | $90.61 | 2019-2024 | Mounjaro, Zepbound |
| Mylan Specialty L.P. | $90.13 | 2023 | Yupelri |
| Genentech USA, INC. | $83.58 | 2019-2022 | |
| Cumberland Pharmaceuticals, INC. | $79.60 | 2019 | |
| Medtronic, INC. | $78.96 | 2021 | |
| Nestle Healthcare Nutrition INC. | $78.06 | 2020-2022 | |
| Abbott Laboratories | $71.19 | 2023-2024 | Freestyle Libre 2, Freestyle Libre, Freestyle Libre 3 |
| Biogen, INC. | $67.35 | 2020-2025 | Leqembi |
| Dexcom, INC. | $67.17 | 2019 | |
| Celgene Corporation | $51.12 | 2019 | |
| Impel Pharmaceuticals INC. | $50.24 | 2022-2023 | Trudhesa |
| Vanda Pharmaceuticals INC. | $49.84 | 2024 | Fanapt, Hetlioz |
| Corium, LLC | $49.75 | 2022-2023 | Adlarity |
| Nevro Corp. | $47.28 | 2021 | |
| Global Blood Therapeutics, INC. | $42.90 | 2022 | |
| Renalytix Ai, INC. | $40.33 | 2024-2025 | Kidneyintelx Blood Collection Convenience Kit |
| Aimmune Therapeutics, INC. | $39.89 | 2024-2025 | Zenpep |
| Biohaven Pharmaceutical Holding Company LTD. | $32.90 | 2022 | |
| Shield Therapeutics INC | $24.92 | 2025 | |
| Althera Pharmaceuticals LLC | $24.00 | 2021 | |
| Avanir Pharmaceuticals, INC. | $23.05 | 2019 | |
| Redhill Biopharma INC. | $20.00 | 2021 | |
| Phadia US INC. | $13.20 | 2021 | |
| Sanofi Pasteur INC. | $12.87 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.75 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Goris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.